ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rybrevant SC 1600 mg/10 ml, Injektionslösung - 
69839001 Janssen-Cilag AG
Rybrevant SC 1600 mg/10 ml, Injektionslösung28.01.2026
  28.01.2026
Amivantamab (L01FX18) 
WHO-DDD27.01.2031
07.16.10. 
07.16.10. 
A  
Yes 
IP 
3538.02Yes
    
10 %3864.25
  
7680698390015Biotechnologika
  
Composition
amivantamabum 1600 mg, hyaluronidasum humanum ADNr, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80, methioninum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 6.19 mg.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Amivantamabum1600mg / 10ml
BAG: Active AgentDose
Amivantamabum1600 mg
 
Inactive agents
Acidum Aceticum Glaciale
Dinatrii Edetas
Hyaluronidasum Humanum Adnr
Methionine
Natrii Acetas Trihydricus
Polysorbatum 80
Saccharum
 
Source
Data was imported : 04.02.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home